Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData
Express Pharma
APRIL 22, 2024
Despite the ongoing uncertainties surrounding macroeconomic activities, fluctuating interest rates, and changes in the Medicare Drug Price Negotiation landscape, the top 20 global biopharma companies experienced a promising first quarter this year. billion in 2024, according to GlobalData’s Drugs Database Pharma Intelligence Center.
Let's personalize your content